# Boston Scientific to acquire Symetis for $435 million

Boston Scientific Corporation announced a definitive agreement to acquire Symetis SA, a Swiss structural heart company, for $435 million in up-front cash. The acquisition expands Boston Scientific's TAVI portfolio and is expected to close in Q2 2017.

- Type: Acquisition
- Announced: 2017-03-30
- Where: Ecublens, Switzerland, Switzerland
- Value: $435.0M
- Status: announced
- Products: transcatheter aortic valve implantation (TAVI) devices
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Boston Scientific](https://endata.com/companies/15966.md) (acquirer)
- [Symetis SA](https://endata.com/companies/23188.md) (target)

## Sources

- [news.bostonscientific.com](https://news.bostonscientific.com/2017-03-30-Boston-Scientific-Announces-Agreement-to-Acquire-Symetis), 2017-03-30: "Boston Scientific Corporation (NYSE: BSX) today announced a definitive agreement to acquire Symetis SA, a privately-held Swiss structural heart company focused on minimally-invasive transcatheter aortic valve implantation (TAVI) devices, for $435 million in up-front cash."
- [sec.gov](https://www.sec.gov/Archives/edgar/data/885725/000088572517000010/symetisacquisitionform8-k.htm), 2017-03-30: "Boston Scientific Corporation announced the signing of a definitive agreement to acquire Symetis SA."
- [reuters.com](https://www.reuters.com/article/brief-symetis-boston-scientific-reach-43/brief-symetis-boston-scientific-reach-435-mln-purchase-agreement-idUSFWN1H70HA/), 2017-03-30: "Symetis and Boston Scientific reach USD 435 million purchase agreement"
- [medicaldevice-network.com](https://www.medicaldevice-network.com/news/newsboston-scientific-to-purchase-symetis-for-435m-5776466/), 2017-04-02: "The ACURATE family of valve products is strongly complementary to our cornerstone Lotus valve platform"

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.